Neuroprotective drops may prevent development, progression of diabetic retinopathy

VIENNA, Austria — Administration of a neuroprotective agent in eye drops may help prevent diabetic retinopathy from developing or progressing, according to one specialist.  “The rationale of our approach is that, at the very early stages of DR, neurodegeneration does exist and is more evident than early microvascular impairment,” Rafael Simό, MD, said at the Advanced Retinal Therapy meeting here.  

Study: Systemic vascular risk higher with intensive treatment with ranibizumab for AMD

An intravitreal dose of ranibizumab for treatment of age-related macular degeneration is small, but it can affect systemic vasculature, according to one study author.“Many ophthalmologists do not realize the possible increase in the systemic vascular risks by injecting ranibizumab for AMD. I assume this is because the frequency of [cerebrovascular accidents] and other systemic vascular adverse events is low — usually up to several percentages of AMD patients per year,” Takashi Ueta, MD, PhD, principal investigator, told Ocular Surgery News. “However, our meta-analysis, by including data for more than 6,500 (Read more...)